Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-19-004879

Options or other derivatives

  • EVP and CMO acquired 201,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lapuerta Pablo · EVP and CMO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +130,710 $5.16 2029-02-07 130,710 130,710 D
2019-02-07 Grant or award : show line 2 in the form Restricted Stock Units +70,390 70,390 70,390 D
Loading xslF345X03/form4.xml…